Not applicableWithdrawnNCT00898612What this trial is testingEarly Detection of Graft-Versus-Host Disease in Patients Undergoing a Donor Bone Marrow TransplantWho this might be right forLymphoma Mayo Clinic
Early research (Phase 1)UnknownNCT00004858What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Recurrent Acute Lymphoblastic Leukemia or Non-Hodgkin's LymphomaWho this might be right forLeukemiaLymphoma Parker Hughes Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00562978What this trial is testingYttrium Y 90 Ibritumomab Tiuxetan, Etoposide, Cyclophosphamide, and an AHSCT in Non-Hodgkin's Lymphoma PatientsWho this might be right forLymphoma City of Hope Medical Center 54
Early research (Phase 1)Ended earlyNCT00725062What this trial is testingDonor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell TransplantWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+2 more Masonic Cancer Center, University of Minnesota 3
Testing effectiveness (Phase 2)Study completedNCT00770224What this trial is testingS0801 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin LymphomaWho this might be right forLymphoma SWOG Cancer Research Network 87
Testing effectiveness (Phase 2)WithdrawnNCT00816413What this trial is testingDonor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more University of Nebraska
Early research (Phase 1)Study completedNCT00019513What this trial is testingCombination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or LymphomasWho this might be right forColorectal CancerEsophageal CancerExtrahepatic Bile Duct Cancer+7 more National Institutes of Health Clinical Center (CC) 108
Not applicableStudy completedNCT00079222What this trial is testingVoriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell TransplantationWho this might be right forCancer Jonsson Comprehensive Cancer Center
Not applicableStudy completedNCT02037256What this trial is testingBortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple MyelomaWho this might be right forAdult Grade III Lymphomatoid GranulomatosisB-cell Chronic Lymphocytic LeukemiaContiguous Stage II Adult Burkitt Lymphoma+86 more Barbara Ann Karmanos Cancer Institute 23
Testing effectiveness (Phase 2)Study completedNCT00003270What this trial is testingChemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic CancerWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+2 more Roswell Park Cancer Institute 20
Early research (Phase 1)Study completedNCT00045500What this trial is testingUCN-01 and Prednisone in Treating Patients With Solid Tumors or LymphomaWho this might be right forLymphomaUnspecified Adult Solid Tumor, Protocol Specific National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00006042What this trial is testingCyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+2 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Early research (Phase 1)Study completedNCT00458731What this trial is testingBevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic AstrocytomaWho this might be right forAdult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+59 more National Cancer Institute (NCI) 57
Not applicableStudy completedNCT00445731What this trial is testingA Structured Walking Program or Standard Therapy in Cancer Patients Undergoing a Donor Bone Marrow TransplantWho this might be right forCancer University of Minnesota 115
Not applicableStudy completedNCT00569309What this trial is testingImmune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk LymphomaWho this might be right forLymphomaMultiple Myeloma and Plasma Cell NeoplasmSmall Intestine Cancer Ohio State University Comprehensive Cancer Center 30
Testing effectiveness (Phase 2)WithdrawnNCT00085449What this trial is testingAlemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+2 more Alliance for Clinical Trials in Oncology
Testing effectiveness (Phase 2)Study completedNCT00003887What this trial is testingLymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell TransplantationWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more Fred Hutchinson Cancer Center
Not applicableStudy completedNCT00453206What this trial is testingDonor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other DiseasesWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more Wake Forest University Health Sciences 66
Testing effectiveness (Phase 2)Study completedNCT00003425What this trial is testingPhase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine CytoprotectWho this might be right forBreast CancerLeukemiaLymphoma+4 more University of Kentucky 25
Early research (Phase 1)Study completedNCT00062140What this trial is testingTotal-Body Irradiation, Cyclophosphamide, and Stem Cell Transplantation in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMyelodysplastic Syndromes+1 more Fred Hutchinson Cancer Center